3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
CNS
1
Conditions
Neuroendocrine Tumors
3
Paraganglioma
2
Neuroblastoma
2
Carcinoid Tumor
2
Tumor Positron-Emission Tomography
1
Pheochromocytoma
1
Meningioma
1
Medulloblastoma
1
Interventions
Temozolomide
6
Radiotherapy
4
Irinotecan
3
lutetium Lu 177 dotatate
2
Nivolumab
2
Carboplatin
2
sonidegib
1
sodium thiosulfate
1
silmitasertib
1
poly ICLC
1
plerixafor
1
olaparib
1
gallium Ga 68 dotatate
1
etoposide phosphate
1
entrectinib
1
dinutuximab
1
bempegaldesleukin
1
adavosertib
1
abemaciclib
1
Vincristine
1
Vascular Endothelial Growth Factor A
1
Vaccines
1
Triiodothyronine
1
TPI-287
1
Surgical Procedures, Operative
1
Radiation
1
Peripheral Blood Stem Cell Transplantation
1
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
1
Microarray Analysis
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Medulloblastoma
×
gallium Ga 68 dotatate
×
Clear all
NCT01619865
2021-07-27
GA-68
University of Iowa
Phase 1/2
Completed
223 enrolled
11 charts